Actively Recruiting
Evaluation of the Aulea Veloxion2 Disposable Resectoscope System for Efficient Surgery in Benign Prostatic Hyperplasia at a Single Site
Led by Chinese University of Hong Kong · Updated on 2026-10-27
20
Participants Needed
1
Research Sites
26 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying the Veloxion2 disposable resectoscope system to evaluate its operational efficiency and safety during endoscopic surgery for benign prostatic hyperplasia BPH. This prospective, single-arm, single-site study focuses on patients with symptomatic BPH aged 30 to 70 years. The study aims to measure procedure times and costs compared to predefined benchmarks while monitoring for any device-related adverse events. Participants will undergo transurethral resection of the prostate TURP using the Aulea Veloxion2 disposable resectoscope system. This single-use device combines fluid management, video, and energy generation to support an automated, motorized resection process. Follow-up occurs at 2 weeks and 1 month after surgery via phone or clinic visits to assess safety, device usability, and the need for any additional interventions. During the study, participants will be monitored for procedure duration, costs, tissue resection times, instrument exchange times, visibility scores, adverse events within 30 days, and staff usability feedback. Safety assessments and usability questionnaires will be conducted during follow-up visits. The total participant involvement lasts about one month after the surgical procedure.
CONDITIONS
Brief Title
Evaluation of the Aulea Veloxion™ Disposable Resectoscope System for Operational Efficiency in Surgical Management of Benign Prostatic Hyperplasia (BPH)
Research Team
A
Alex Qinyang LIU, MBBS, MSc, FRCSEd
C
Chi Fai NG, MBChB, MD, FRCSEd
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here